Class II Drug D-0723-2026 Ongoing

When an emergency kit is hard to press — a gliding force out of specification

Lupin Pharmaceuticals Inc. Reported Jul 8, 2026

A glucagon emergency kit for low blood sugar was recalled after the gliding force functionality test returned an out-of-specification result during twelve-month long-term stability testing, recorded as a CGMP deviation.

Recall overview (primary data)

  • ClassificationClass II
  • Product typeDrug
  • Recalling firmLupin Pharmaceuticals Inc.
  • ReasonCGMP deviation: OOS result observed for the Gliding Force functionality test during 12-month long term stability testing.
  • DistributionNationwide within the U.S.
  • Recall initiated2026-06-23

Key points

  • The product is the Glucagon Emergency Kit for Low Blood Sugar, 1 mg per vial with a 1 mL syringe of diluent, NDC 70748-311-01.
  • The reason is an out-of-specification result for the gliding force functionality test during twelve-month long-term stability testing.
  • It is recorded as a deviation from current good manufacturing practice.
  • Gliding force is the force required to depress a syringe plunger, and the emergency setting changes what that means.
  • The recalling firm is Lupin Pharmaceuticals Inc., the quantity 64,894 units, distributed nationwide.

1When being hard to press becomes the problem

Gliding force is the force required to depress the plunger of a syringe. For an ordinary injectable, a stiff plunger is an inconvenience and the dose still goes in. This kit, though, is for an emergency in low blood sugar. The setting in which it is used changes what stiffness means.

2Who uses it, and when

The aspectAn ordinary injectableThis glucagon emergency kit
Who administers itA healthcare professionalPossibly the patient, or someone nearby
The settingA planned administrationAn episode of low blood sugar, needing speed
What is requiredAccurate administrationBeing able to administer quickly
If the gliding force is highAdministration takes longerFumbling at a moment that will not wait

A physical property of the device takes its meaning from the urgency of the setting. Glucagon raises blood sugar and is given in severe hypoglycaemia. That context is why stiffness may amount to more than inconvenience.

3The words during twelve-month stability testing

  1. 1What was measuredThe gliding force functionality test
  2. 2WhenAt the twelve-month point of long-term stability testing
  3. 3The resultOut of specification
  4. 4How it is recordedA deviation from current good manufacturing practice

The product was not out of specification at release. The record is that testing at twelve months found it outside. Stability testing exists to confirm that a product stays within specification across its labelled period; the same structure as the shelf life in the previous article appears here as a measured value.

4The scale

Of the 1,408 records this site holds as of 2026-09-05, those without an article1,31523 (1.7%) mention stability testing
Quantity in this recall64,894 unitsDistributed nationwide
How it was foundIn-house testing54 (4.1%) of those 1,315 mention in-house testing

The firm found it in its own testing, not through a complaint or an inspection, but within the stability programme it is required to run. Firms themselves initiate 98.8% of these recalls, and this is one of them.

Why it matters

A physical property of a device takes its meaning from the urgency of the setting it is used in. A stiff plunger may be mere inconvenience in a planned injection and an obstacle to administration itself in a hypoglycaemic emergency. Stability testing, meanwhile, exists to confirm conformity not at release but after time has passed, and this record is an instance of that mechanism doing its work.

FAQ

What is gliding force?
The force required to depress the plunger of a syringe. Here its functionality test fell outside specification at the twelve-month point.
Why does it matter for an emergency kit?
Because the kit is used during an episode of low blood sugar, possibly by the patient or someone nearby, where administering quickly is what is required.
Was it out of specification at release?
The record gives the result as arising during twelve-month long-term stability testing and says nothing about conformity at release.

Sources (primary)

Source: openFDA (U.S. FDA, CC0 public domain). Data is provided as-is and must not be used for medical decisions. Verify the latest and exact details with the official FDA recall information. This site is not endorsed or certified by the U.S. FDA.

#FDA recalls#Drugs#Hypoglycaemia#United States#Product safety
Disclaimer: This site independently summarizes and classifies information based on official data sources. Always verify the latest and accurate information with the official sources. Content on finance, health, legal, and security is information, not advice. This site is not an official website of the U.S. government.